Brazil is now facing an endemic of dengue, having seen a significant seasonal increase of over 4.5 million in the number of probable cases reported. Imaging exams such as ultrasound, computed ...

Pancreatic cancer, one of the most formidable, could soon see its treatment transformed. Researchers have identified an enzyme, Mical2, which plays a central role in the progression of this disease.

Background and Aim: We report our single-centre experience with endoscopic ultrasound guided fine needle aspiration (EUS-FNA) of solid pancreatic lesions with regard to clinical utility ...

An experimental blood test for pancreatic cancer is being evaluated by a commercial laboratory, an important milestone toward making the test available for patients. An experimental blood test for ...

Background The immune suppression mechanisms in pancreatic ductal adenocarcinoma (PDAC) remain unknown, but preclinical studies have implicated macrophage-mediated immune tolerance. Hence, pathways ...

What is a 5-year relative survival rate? Where do these numbers come from? 5-year relative survival rates for pancreatic cancer Understanding the numbers Keep in mind that survival rates are estimates ...

An enzyme called MICAL2 promotes tumor growth and metastasis in the most common form of pancreatic cancer, according to a new study. Pancreatic cancer kills 50,000 people each year, according to ...

Methods: The clinical and ultrasound features of fibrous pseudotumor of the tunica vaginalis diagnosed by pathology in West China Hospital of Sichuan University from 2006 to 2023 were retrospectively ...

Doctors don’t know what causes pancreatic cancer, but some things can increase your risk of developing it (risk factors). About 10,500 people are diagnosed with pancreatic cancer in the UK each year.